RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 Early Routine Eptifibatide Use is Not Superior to Delayed Provisional Use in NSTE ACS
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 9
IS 2
SP 17
OP 20
DO 10.1177/155989770902009
UL http://mdc.sagepub.com/content/9/2/17.abstract
AB The early routine administration of eptifibatide is not superior to delayed provisional eptifibatide use among invasively managed patients with high-risk non-ST-segment elevation acute coronary syndrome (NSTE ACS), according to findings from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes [EARLY-ACS; NCT00089895] study. Moreover, compared with delayed use, early eptifibatide use increases bleeding and transfusion rates.